JPWO2020022507A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020022507A5 JPWO2020022507A5 JP2020532517A JP2020532517A JPWO2020022507A5 JP WO2020022507 A5 JPWO2020022507 A5 JP WO2020022507A5 JP 2020532517 A JP2020532517 A JP 2020532517A JP 2020532517 A JP2020532517 A JP 2020532517A JP WO2020022507 A5 JPWO2020022507 A5 JP WO2020022507A5
- Authority
- JP
- Japan
- Prior art keywords
- benzyloxyphenylthio
- chlorophenyl
- diol
- propane
- ethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018141411 | 2018-07-27 | ||
| JP2018141411 | 2018-07-27 | ||
| JP2019036598 | 2019-02-28 | ||
| JP2019036598 | 2019-02-28 | ||
| PCT/JP2019/029524 WO2020022507A1 (ja) | 2018-07-27 | 2019-07-26 | 造血幹細胞移植を受けた患者における血液悪性腫瘍の再発抑制剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2020022507A1 JPWO2020022507A1 (ja) | 2021-08-05 |
| JPWO2020022507A5 true JPWO2020022507A5 (https=) | 2022-07-28 |
| JP7389486B2 JP7389486B2 (ja) | 2023-11-30 |
Family
ID=69181631
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020532517A Active JP7389486B2 (ja) | 2018-07-27 | 2019-07-26 | 造血幹細胞移植を受けた患者における血液悪性腫瘍の再発抑制剤 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20210283073A1 (https=) |
| EP (1) | EP3831370A4 (https=) |
| JP (1) | JP7389486B2 (https=) |
| KR (1) | KR102948053B1 (https=) |
| CN (2) | CN112512516A (https=) |
| AU (1) | AU2019311609B2 (https=) |
| BR (1) | BR112021001376A2 (https=) |
| IL (1) | IL280451B2 (https=) |
| MX (1) | MX2021001039A (https=) |
| TW (1) | TWI899057B (https=) |
| WO (1) | WO2020022507A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021424131A1 (en) * | 2021-01-28 | 2023-07-27 | Priothera Limited | Methods of treatment with s1p receptor modulators |
| EP4248958A3 (en) | 2021-01-28 | 2024-01-03 | Priothera SAS | Methods of treatment with s1p receptor modulators |
| EP4282407A1 (en) | 2022-05-27 | 2023-11-29 | Priothera SAS | Treatment of cancer with s1p receptor agonists |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1431275B1 (en) | 2001-09-27 | 2010-04-07 | Kyorin Pharmaceutical Co., Ltd. | Diaryl ether derivative, addition salt thereof, and immunosuppressant |
| MXPA04002679A (es) | 2001-09-27 | 2004-07-30 | Kyorin Seiyaku Kk | Derivados de sulfuro de diarilo, sales de los mismos y agentes inmunosupresores que utilizan los mismos. |
| CN101014329B (zh) * | 2004-07-16 | 2010-09-08 | 杏林制药株式会社 | 用于对器官或组织的移植的排异反应或骨髓移植的移植物抗宿主反应预防或治疗的药物组合物 |
| EP1806338B1 (en) | 2004-10-12 | 2016-01-20 | Kyorin Pharmaceutical Co., Ltd. | Process for producing 2-amino-2-[2-[4-(3-benzyloxy-phenylthio)-2-chlorophenyl[ethyl]-1,3-propanediol hydrochloride and hydrates thereof. and intermediates the production thereof |
| SI1932522T1 (sl) | 2005-10-07 | 2012-08-31 | Kyorin Seiyaku Kk | Terapevtsko sredstvo za jetrno bolezen, ki vsebuje 2-amino-1,3- propandiolni derivat kot aktivno sestavino |
| TWI389683B (zh) | 2006-02-06 | 2013-03-21 | Kyorin Seiyaku Kk | A therapeutic agent for an inflammatory bowel disease or an inflammatory bowel disease treatment using a 2-amino-1,3-propanediol derivative as an active ingredient |
| AU2009206733A1 (en) * | 2008-01-25 | 2009-07-30 | Arena Pharmaceuticals, Inc. | Dihydro- 1H- pyrrolo [1,2-a] indol-1-yl carboxylic derivatives which act as S1P1 agonists |
| WO2014120949A1 (en) * | 2013-01-30 | 2014-08-07 | Memorial Sloan-Kettering Cancer Center | Donor kir3dl1 and hla-b subtypes and leukemia control in hla-compatible allogenic hematopoietic stem cell transplantation |
| US20160000811A1 (en) * | 2013-02-20 | 2016-01-07 | Novartis Ag | Treatment of graft versus host disease in transplant patients |
| US10154989B2 (en) * | 2015-09-17 | 2018-12-18 | Emory University | Methods of managing graft versus host disease (GvHD) using indole carboxyaldehydes or derivatives thereof |
| WO2017153889A1 (en) | 2016-03-08 | 2017-09-14 | Novartis Ag | Treatment of hematopoietic stem cell transplant patients |
-
2019
- 2019-07-26 CN CN201980050102.5A patent/CN112512516A/zh active Pending
- 2019-07-26 EP EP19842105.9A patent/EP3831370A4/en active Pending
- 2019-07-26 CN CN202510467128.7A patent/CN120284929A/zh active Pending
- 2019-07-26 AU AU2019311609A patent/AU2019311609B2/en active Active
- 2019-07-26 MX MX2021001039A patent/MX2021001039A/es unknown
- 2019-07-26 BR BR112021001376-8A patent/BR112021001376A2/pt unknown
- 2019-07-26 WO PCT/JP2019/029524 patent/WO2020022507A1/ja not_active Ceased
- 2019-07-26 US US17/263,440 patent/US20210283073A1/en active Pending
- 2019-07-26 JP JP2020532517A patent/JP7389486B2/ja active Active
- 2019-07-26 IL IL280451A patent/IL280451B2/en unknown
- 2019-07-26 TW TW108126590A patent/TWI899057B/zh active
- 2019-07-26 KR KR1020217002596A patent/KR102948053B1/ko active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023041862A5 (https=) | ||
| Zorzi et al. | A phase I study of histone deacetylase inhibitor, pracinostat (SB939), in pediatric patients with refractory solid tumors: IND203 a trial of the NCIC IND program/C17 pediatric phase I consortium | |
| JP2021066744A5 (ja) | ブプロピオンおよびデキストロメトルファンを含む組成物 | |
| JP2009545620A5 (https=) | ||
| ZA202202361B (en) | Treatment of hidradenitis suppurativa using jak inhibitors | |
| JPWO2020022507A5 (https=) | ||
| JP2019515909A5 (https=) | ||
| JP2007520506A5 (https=) | ||
| JP2019508476A5 (https=) | ||
| JP2016509050A5 (https=) | ||
| JP2019526559A5 (https=) | ||
| CN115916778A (zh) | 甲硫氨酸腺苷转移酶抑制剂、其制备方法及应用 | |
| JP2020529995A5 (https=) | ||
| CL2024003601A1 (es) | Nuevas combinaciones terapéuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| JP2005508896A5 (https=) | ||
| JP2012525358A5 (https=) | ||
| JP2016505050A5 (https=) | ||
| JP2014534229A5 (https=) | ||
| TWI899057B (zh) | 接受造血幹細胞移植的患者之血液惡性腫瘤的復發抑制劑 | |
| JP2019535830A5 (https=) | ||
| JPWO2017184774A5 (https=) | ||
| CN115279344A (zh) | 盐酸米托蒽醌脂质体的用途 | |
| WO2004043336A3 (en) | Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of myeloproliferative diseases | |
| IL275091B2 (en) | Methods for treating gaucher disease | |
| AU2017231000B2 (en) | Treatment of hematopoietic stem cell transplant patients |